A new study to be presented at the SLEEP 2024 annual meeting, held in Houston, Texas, June 1–5, is the first to find that episodic hypoxemia and hypoxic burden related to obstructive sleep apnea are associated with the risk of accelerated lung cancer reoccurrence.
This article was originally published on MedicalXpress.com